UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of
Report (Date of earliest event reported):
December 21, 2007
PRESTIGE
BRANDS HOLDINGS, INC.
(Exact
name of registrant as specified in its
charter)
|
Delaware
|
001-32433
|
20-1297589
|
|
(State
or other jurisdiction
|
(Commission
File Number)
|
(IRS
Employer |
|
of
incorporation)
|
|
Identification
No.)
|
90
North Broadway, Irvington, New York 10533
(Address
of principal
executive offices, including Zip Code)
(914)
524-6810
(Registrant’s
telephone
number, including area code)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
[ ]
Written
communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[ ]
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act
(17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act
(17 CFR 240.13e-4(c))
Item
1.01 Entry into a Material Definitive Agreement.
On
December 21, 2007,
Medtech Products Inc. (“Medtech”), an indirect wholly-owned subsidiary of
Prestige Brands Holdings, Inc., entered into two Contract Manufacturing
Agreements with Pharmaspray B.V. for the supply of
cryogenic wart removers. The contracts each have initial three-year terms
and
provide for Pharmaspray to be the exclusive manufacturer of the Wartner® and Compound W® Freeze Off® brands, respectively, that are
distributed in certain markets designated in the contracts.
SIGNATURES
Pursuant
to the
requirements of the Securities
Exchange Act of 1934, the Registrant
has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| Dated:
December 27, 2007 |
|
PRESTIGE
BRANDS
HOLDINGS, INC.
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
By: |
/s/
Charles N.
Jolly |
| |
|
|
Name:
Charles N. Jolly |
| |
|
|
Title:
General Counsel and Secretary |
| |
|
|
|